Suboptimal monitoring and management in patients with unrecorded stage 3 chronic kidney disease in real-world settings: Insights from REVEAL-CKD.

Navdeep TangriChristian S AlvarezMatthew ArnoldSalvatore BaroneAna CebriánHungta ChenLuca De NicolaKrister JärbrinkNaresh KanumilliKean-Seng LimToshiki MoriyamaRoberto Pecoits FilhoMaria Cristina Ribeiro de CastroRafael SantamariaMarkus P SchneiderJean Blaise VirgittiPamela Kushner

Published in: European journal of clinical investigation (2024)

Overall, a large proportion of patients with evidence of stage 3 CKD did not receive recommended, guideline-directed monitoring and management. The variability in standard of care among countries demonstrates a clear opportunity to improve monitoring and management of these patients, most likely improving long-term outcomes.

Keyphrases

chronic kidney disease
end stage renal disease
healthcare
ejection fraction
newly diagnosed
palliative care
prognostic factors
single cell
genome wide
patient reported outcomes
pain management